An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study
T. Grushko(University of Chicago Medical Center), Gini F. Fleming(University of Chicago), Arno J. Mundt(Sutter Health), Virginia L. Filiaci(Roswell Park Comprehensive Cancer Center), Karin Ridderstråle(University of Chicago Medical Center), Olufunmilayo I. Olopade(University of Chicago)
Cited by 181
Related Papers
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
|Genome biology|2007|1.3k
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533